ZAMAGNI, ELENA
ZAMAGNI, ELENA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di IIa fascia
Elena Zamagni; E. Zamagni; ZAMAGNI E
Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma
2024 Mateos, Maria Victoria; Weisel, Katja; Terpos, Evangelos; Delimpasi, Sossana; Kastritis, Efstathios; Zamagni, Elena; Delforge, Michel; Ocio, Enrique; Katodritou, Eirini; Gay, Francesca; Larocca, Alessandra; Leleu, Xavier; Otero, Paula Rodriguez; Schjesvold, Fredik; Cavo, Michele; Dimopoulos, Meletios A.
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials
2024 Gentile M.; Vigna E.; Palmieri S.; Galli M.; Derudas D.; Mina R.; Pepa R.D.; Zambello R.; Martino E.A.; Bruzzese A.; Mangiacavalli S.; Zamagni E.; Califano C.; Musso M.; Conticello C.; Cerchione C.; Mele G.; Renzo N.D.; Offidani M.; Tarantini G.; Casaluci G.M.; Rago A.; Ria R.; Uccello G.; Barilà G.; Palumbo G.; Pompa A.; Vincelli D.; Brunori M.; Accardi F.; Amico V.; Amendola A.; Fontana R.; Bongarzoni V.; Rossini B.; Cotzia E.; Gozzetti A.; Rizzi R.; Sgherza N.; Ferretti E.; Bertuglia G.; Nappi D.; Petrucci M.T.; Raimondo F.D.; Neri A.; Morabito F.; Musto P.
Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients—A Systematic Review
2024 Bigi F.; Manzato E.; Barbato S.; Talarico M.; Puppi M.; Masci S.; Sacchetti I.; Restuccia R.; Iezza M.; Rizzello I.; Sartor C.; Mancuso K.; Pantani L.; Tacchetti P.; Cavo M.; Zamagni E.
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma
2024 Rodriguez-Otero, Paula; Usmani, Saad; Cohen, Adam D; van de Donk, Niels W C J; Leleu, Xavier; Pérez-Larraya, Jaime Gállego; Manier, Salomon; Nooka, Ajay K; Mateos, Maria Victoria; Einsele, Hermann; Minnema, Monique; Cavo, Michele; Derman, Benjamin A; Puig, Noemi; Gay, Francesca; Ho, P Joy; Chng, Wee-Joo; Kastritis, Efstathios; Gahrton, Gösta; Weisel, Katja; Nagarajan, Chandramouli; Schjesvold, Fredik; Mikhael, Joseph; Costa, Luciano; Raje, Noopur S; Zamagni, Elena; Hájek, Roman; Weinhold, Niels; Yong, Kwee; Ye, Jing Christine; Sidhana, Surbhi; Merlini, Giampaolo; Martin, Tom; Lin, Yi; Chari, Ajai; Popat, Rakesh; Kaufman, Jonathan L
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
2024 Facon, Thierry; Dimopoulos, Meletios-Athanasios; Leleu, Xavier P.; Beksac, Meral; Pour, Ludek; Hájek, Roman; Liu, Zhuogang; Minarik, Jiri; Moreau, Philippe; Romejko-Jarosinska, Joanna; Spicka, Ivan; Vorobyev, Vladimir I.; Besemer, Britta; Ishida, Tadao; Janowski, Wojciech; Kalayoglu-Besisik, Sevgi; Parmar, Gurdeep; Robak, Pawel; Zamagni, Elena; Goldschmidt, Hartmut; Martin, Thomas G.; Manier, Salomon; Mohty, Mohamad; Oprea, Corina; Brégeault, Marie-France; Macé, Sandrine; Berthou, Christelle; Bregman, David; Klippel, Zandra; Orlowski, Robert Z.
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features
2024 Terragna C.; Poletti A.; Solli V.; Martello M.; Zamagni E.; Pantani L.; Borsi E.; Vigliotta I.; Mazzocchetti G.; Armuzzi S.; Taurisano B.; Testoni N.; Marzocchi G.; Kanapari A.; Pistis I.; Tacchetti P.; Mancuso K.; Rocchi S.; Rizzello I.; Cavo M.
Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment—67 Patients Multicenter Analysis
2024 Charliński G.; Steinhardt M.; Rasche L.; Gonzalez-Calle V.; Peña C.; Parmar H.; Wiśniewska-Piąty K.; Dávila Valls J.; Olszewska-Szopa M.; Usnarska-Zubkiewicz L.; Gozzetti A.; Ciofini S.; Gentile M.; Zamagni E.; Kurlapski M.; Legieć W.; Vesole D.H.; Jurczyszyn A.
Severe SARS-CoV-2 and subsequent fungal infections after CAR T-cell therapy for relapsed/refractory multiple myeloma: a challenging and happy ending fight
2024 Ielo, Claudia; Fazio, Francesca; Rocchi, Serena; Rizzello, Ilaria; Mancuso, Katia; Zamagni, Elena; Cavo, Michele; Petrucci, Maria Teresa
Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients
2024 Borsi, Enrica; Vigliotta, Ilaria; Poletti, Andrea; Mazzocchetti, Gaia; Solli, Vincenza; Zazzeroni, Luca; Martello, Marina; Armuzzi, Silvia; Taurisano, Barbara; Kanapari, Ajsi; Pistis, Ignazia; Zamagni, Elena; Pantani, Lucia; Rocchi, Serena; Mancuso, Katia; Tacchetti, Paola; Rizzello, Ilaria; Rizzi, Simonetta; Dan, Elisa; Sinigaglia, Barbara; Cavo, Michele; Terragna, Carolina
Which is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome?
2024 Autore, Francesco; Bramanti, Stefania; Lessi, Federica; Innocenti, Idanna; Galli, Eugenio; Rocchi, Serena; Ribolla, Rossella; Derudas, Daniele; Oliva, Stefania; Stefanoni, Paola; Marcatti, Magda; Schenone, Angelo; La Nasa, Giorgio; Crippa, Claudia; Zamagni, Elena; Riva, Marcello; Mazza, Rita; Mannina, Daniele; Sica, Simona; Bacigalupo, Andrea; Laurenti, Luca
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial
2023 Mina R.; Musto P.; Rota-Scalabrini D.; Paris L.; Gamberi B.; Palmas A.; Aquino S.; de Fabritiis P.; Giuliani N.; De Rosa L.; Gozzetti A.; Cellini C.; Bertamini L.; Capra A.; Oddolo D.; Vincelli I.D.; Ronconi S.; Pavone V.; Pescosta N.; Cea M.; Fioritoni F.; Ballanti S.; Grasso M.; Zamagni E.; Belotti A.; Boccadoro M.; Gay F.
Difficult‐to‐treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results
2023 Raab, Marc S.; Zamagni, Elena; Manier, Salomon; Rodriguez‐Otero, Paula; Schjesvold, Fredrik; Broijl, Annemiek
European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours
2023 Nanni, Cristina; Kobe, Carsten; Baeßler, Bettina; Baues, Christian; Boellaard, Ronald; Borchmann, Peter; Buck, Andreas; Buvat, Irène; Chapuy, Björn; Cheson, Bruce D; Chrzan, Robert; Cottereau, Ann-Segolene; Dührsen, Ulrich; Eikenes, Live; Hutchings, Martin; Jurczak, Wojciech; Kraeber-Bodéré, Françoise; Lopci, Egesta; Luminari, Stefano; MacLennan, Steven; Mikhaeel, N George; Nijland, Marcel; Rodríguez-Otero, Paula; Treglia, Giorgio; Withofs, Nadia; Zamagni, Elena; Zinzani, Pier Luigi; Zijlstra, Josée M; Herrmann, Ken; Kunikowska, Jolanta
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients
2023 Borsi E.; Mazzocchetti G.; Dico A.F.; Vigliotta I.; Martello M.; Poletti A.; Solli V.; Armuzzi S.; Taurisano B.; Kanapari A.; Pistis I.; Zamagni E.; Tacchetti P.; Pantani L.; Mancuso K.; Rocchi S.; Rizzello I.; Cavo M.; Terragna C.
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial
2023 Zamagni E.; Oliva S.; Gay F.; Capra A.; Rota-Scalabrini D.; D'Agostino M.; Belotti A.; Galli M.; Racca M.; Zambello R.; Gamberi B.; Albano D.; Bertamini L.; Versari A.; Grasso M.; Sgherza N.; Priola C.; Fioritoni F.; Patriarca F.; De Cicco G.; Villanova T.; Pascarella A.; Zucchetta P.; Tacchetti P.; Fanti S.; Mancuso K.; Barbato S.; Boccadoro M.; Musto P.; Cavo M.; Nanni C.
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma
2023 Mancuso K.; Zamagni E.; Solli V.; Gabrielli L.; Leone M.; Pantani L.; Rocchi S.; Rizzello I.; Tacchetti P.; Ghibellini S.; Favero E.; Ursi M.; Talarico M.; Barbato S.; Kanapari A.; Bigi F.; Puppi M.; Terragna C.; Borsi E.; Martello M.; Poletti A.; Scata A.; Nepoti G.; Ruffini B.; Lazzarotto T.; Cavo M.
Multidisciplinary Management of Sternal Osteomyelitis Due to Klebsiella aerogenes after Open Heart Surgery in a Patient with Multiple Myeloma: A Case Report and Discussion of the Literature
2023 Pignatti, Marco; Dolci, Giampiero; Zamagni, Elena; Pascale, Renato; Piccin, Ottavio; Ammar, Alessandro; Zeneli, Flavia; Miralles, Maria Elisa Lozano; Mancuso, Katia; Cipriani, Riccardo; Viale, Pierluigi; Pacini, Davide; Martin-Suàrez, Sofia
Multiple Myeloma Prognosis From PET Images: Deep Survival Losses and Contrastive Pretraining
2023 Morvan L.; Nanni C.; Michaud A.-V.; Jamet B.; Bailly C.; Bodet-Milin C.; Chauvie S.; Touzeau C.; Moreau P.; Zamagni E.; Kraeber-Bodere F.; Carlier T.; Mateus D.
New Developments in Myeloma Treatment and Response Assessment
2023 Kraeber-Bodere F.; Jamet B.; Bezzi D.; Zamagni E.; Moreau P.; Nanni C.
Oxytocin modulates osteogenic commitment in human adipose-derived mesenchymal stem cells
2023 Giovannamaria Petrocelli, Provvidenza Maria Abruzzo, Luca Pampanella, Riccardo Tassinari, Serena Marini, Martina Fazzina, Elena Zamagni, Carlo Ventura, Federica Facchin, Silvia Canaider
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma | Mateos, Maria Victoria; Weisel, Katja; Terpos, Evangelos; Delimpasi, Sossana; Kastritis, Efstathi...os; Zamagni, Elena; Delforge, Michel; Ocio, Enrique; Katodritou, Eirini; Gay, Francesca; Larocca, Alessandra; Leleu, Xavier; Otero, Paula Rodriguez; Schjesvold, Fredik; Cavo, Michele; Dimopoulos, Meletios A. | 2024-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials | Gentile M.; Vigna E.; Palmieri S.; Galli M.; Derudas D.; Mina R.; Pepa R.D.; Zambello R.; Martino... E.A.; Bruzzese A.; Mangiacavalli S.; Zamagni E.; Califano C.; Musso M.; Conticello C.; Cerchione C.; Mele G.; Renzo N.D.; Offidani M.; Tarantini G.; Casaluci G.M.; Rago A.; Ria R.; Uccello G.; Barilà G.; Palumbo G.; Pompa A.; Vincelli D.; Brunori M.; Accardi F.; Amico V.; Amendola A.; Fontana R.; Bongarzoni V.; Rossini B.; Cotzia E.; Gozzetti A.; Rizzi R.; Sgherza N.; Ferretti E.; Bertuglia G.; Nappi D.; Petrucci M.T.; Raimondo F.D.; Neri A.; Morabito F.; Musto P. | 2024-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | 11157-Article Text-81532-2-10-20231227.pdf |
Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients—A Systematic Review | Bigi F.; Manzato E.; Barbato S.; Talarico M.; Puppi M.; Masci S.; Sacchetti I.; Restuccia R.; Iez...za M.; Rizzello I.; Sartor C.; Mancuso K.; Pantani L.; Tacchetti P.; Cavo M.; Zamagni E. | 2024-01-01 | PHARMACEUTICALS | - | 1.01 Articolo in rivista | pharmaceuticals-17-00944.pdf; pharmaceuticals-17-00944-s001.zip |
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma | Rodriguez-Otero, Paula; Usmani, Saad; Cohen, Adam D; van de Donk, Niels W C J; Leleu, Xavier; Pér...ez-Larraya, Jaime Gállego; Manier, Salomon; Nooka, Ajay K; Mateos, Maria Victoria; Einsele, Hermann; Minnema, Monique; Cavo, Michele; Derman, Benjamin A; Puig, Noemi; Gay, Francesca; Ho, P Joy; Chng, Wee-Joo; Kastritis, Efstathios; Gahrton, Gösta; Weisel, Katja; Nagarajan, Chandramouli; Schjesvold, Fredik; Mikhael, Joseph; Costa, Luciano; Raje, Noopur S; Zamagni, Elena; Hájek, Roman; Weinhold, Niels; Yong, Kwee; Ye, Jing Christine; Sidhana, Surbhi; Merlini, Giampaolo; Martin, Tom; Lin, Yi; Chari, Ajai; Popat, Rakesh; Kaufman, Jonathan L | 2024-01-01 | THE LANCET ONCOLOGY | - | 1.01 Articolo in rivista | - |
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma | Facon, Thierry; Dimopoulos, Meletios-Athanasios; Leleu, Xavier P.; Beksac, Meral; Pour, Ludek; Há...jek, Roman; Liu, Zhuogang; Minarik, Jiri; Moreau, Philippe; Romejko-Jarosinska, Joanna; Spicka, Ivan; Vorobyev, Vladimir I.; Besemer, Britta; Ishida, Tadao; Janowski, Wojciech; Kalayoglu-Besisik, Sevgi; Parmar, Gurdeep; Robak, Pawel; Zamagni, Elena; Goldschmidt, Hartmut; Martin, Thomas G.; Manier, Salomon; Mohty, Mohamad; Oprea, Corina; Brégeault, Marie-France; Macé, Sandrine; Berthou, Christelle; Bregman, David; Klippel, Zandra; Orlowski, Robert Z. | 2024-01-01 | THE NEW ENGLAND JOURNAL OF MEDICINE | - | 1.01 Articolo in rivista | - |
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features | Terragna C.; Poletti A.; Solli V.; Martello M.; Zamagni E.; Pantani L.; Borsi E.; Vigliotta I.; M...azzocchetti G.; Armuzzi S.; Taurisano B.; Testoni N.; Marzocchi G.; Kanapari A.; Pistis I.; Tacchetti P.; Mancuso K.; Rocchi S.; Rizzello I.; Cavo M. | 2024-01-01 | NATURE COMMUNICATIONS | - | 1.01 Articolo in rivista | 41467_2024_Article_45000.pdf; 41467_2024_45000_MOESM7_ESM.zip |
Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment—67 Patients Multicenter Analysis | Charliński G.; Steinhardt M.; Rasche L.; Gonzalez-Calle V.; Peña C.; Parmar H.; Wiśniewska-Piąty ...K.; Dávila Valls J.; Olszewska-Szopa M.; Usnarska-Zubkiewicz L.; Gozzetti A.; Ciofini S.; Gentile M.; Zamagni E.; Kurlapski M.; Legieć W.; Vesole D.H.; Jurczyszyn A. | 2024-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-16-01592-v2.pdf |
Severe SARS-CoV-2 and subsequent fungal infections after CAR T-cell therapy for relapsed/refractory multiple myeloma: a challenging and happy ending fight | Ielo, Claudia; Fazio, Francesca; Rocchi, Serena; Rizzello, Ilaria; Mancuso, Katia; Zamagni, Elena...; Cavo, Michele; Petrucci, Maria Teresa | 2024-01-01 | LEUKEMIA RESEARCH REPORTS | - | 1.01 Articolo in rivista | Severe SARS-CoV-2.pdf |
Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients | Borsi, Enrica; Vigliotta, Ilaria; Poletti, Andrea; Mazzocchetti, Gaia; Solli, Vincenza; Zazzeroni..., Luca; Martello, Marina; Armuzzi, Silvia; Taurisano, Barbara; Kanapari, Ajsi; Pistis, Ignazia; Zamagni, Elena; Pantani, Lucia; Rocchi, Serena; Mancuso, Katia; Tacchetti, Paola; Rizzello, Ilaria; Rizzi, Simonetta; Dan, Elisa; Sinigaglia, Barbara; Cavo, Michele; Terragna, Carolina | 2024-01-01 | CELLS | - | 1.01 Articolo in rivista | cells-13-00657-v2.pdf; cells-13-00657-s001.zip |
Which is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome? | Autore, Francesco; Bramanti, Stefania; Lessi, Federica; Innocenti, Idanna; Galli, Eugenio; Rocchi..., Serena; Ribolla, Rossella; Derudas, Daniele; Oliva, Stefania; Stefanoni, Paola; Marcatti, Magda; Schenone, Angelo; La Nasa, Giorgio; Crippa, Claudia; Zamagni, Elena; Riva, Marcello; Mazza, Rita; Mannina, Daniele; Sica, Simona; Bacigalupo, Andrea; Laurenti, Luca | 2024-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | Autore_2024.pdf |
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial | Mina R.; Musto P.; Rota-Scalabrini D.; Paris L.; Gamberi B.; Palmas A.; Aquino S.; de Fabritiis P....; Giuliani N.; De Rosa L.; Gozzetti A.; Cellini C.; Bertamini L.; Capra A.; Oddolo D.; Vincelli I.D.; Ronconi S.; Pavone V.; Pescosta N.; Cea M.; Fioritoni F.; Ballanti S.; Grasso M.; Zamagni E.; Belotti A.; Boccadoro M.; Gay F. | 2023-01-01 | THE LANCET ONCOLOGY | - | 1.01 Articolo in rivista | - |
Difficult‐to‐treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results | Raab, Marc S.; Zamagni, Elena; Manier, Salomon; Rodriguez‐Otero, Paula; Schjesvold, Fredrik; Broi...jl, Annemiek | 2023-01-01 | EJHAEM | - | 1.01 Articolo in rivista | eJHaem - 2023 - Raab - Difficult‐to‐treat patients with relapsed refractory multiple myeloma A review of clinical trial.pdf |
European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours | Nanni, Cristina; Kobe, Carsten; Baeßler, Bettina; Baues, Christian; Boellaard, Ronald; Borchmann,... Peter; Buck, Andreas; Buvat, Irène; Chapuy, Björn; Cheson, Bruce D; Chrzan, Robert; Cottereau, Ann-Segolene; Dührsen, Ulrich; Eikenes, Live; Hutchings, Martin; Jurczak, Wojciech; Kraeber-Bodéré, Françoise; Lopci, Egesta; Luminari, Stefano; MacLennan, Steven; Mikhaeel, N George; Nijland, Marcel; Rodríguez-Otero, Paula; Treglia, Giorgio; Withofs, Nadia; Zamagni, Elena; Zinzani, Pier Luigi; Zijlstra, Josée M; Herrmann, Ken; Kunikowska, Jolanta | 2023-01-01 | THE LANCET. HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients | Borsi E.; Mazzocchetti G.; Dico A.F.; Vigliotta I.; Martello M.; Poletti A.; Solli V.; Armuzzi S....; Taurisano B.; Kanapari A.; Pistis I.; Zamagni E.; Tacchetti P.; Pantani L.; Mancuso K.; Rocchi S.; Rizzello I.; Cavo M.; Terragna C. | 2023-01-01 | CLINICAL AND EXPERIMENTAL MEDICINE | - | 1.01 Articolo in rivista | s10238-023-01205-y.pdf; 10238_2023_1205_MOESM1_ESM.docx; 10238_2023_1205_MOESM2_ESM.docx |
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial | Zamagni E.; Oliva S.; Gay F.; Capra A.; Rota-Scalabrini D.; D'Agostino M.; Belotti A.; Galli M.; ...Racca M.; Zambello R.; Gamberi B.; Albano D.; Bertamini L.; Versari A.; Grasso M.; Sgherza N.; Priola C.; Fioritoni F.; Patriarca F.; De Cicco G.; Villanova T.; Pascarella A.; Zucchetta P.; Tacchetti P.; Fanti S.; Mancuso K.; Barbato S.; Boccadoro M.; Musto P.; Cavo M.; Nanni C. | 2023-01-01 | ECLINICALMEDICINE | - | 1.01 Articolo in rivista | PIIS2589537023001943.pdf; mmc1 (1).pdf |
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma | Mancuso K.; Zamagni E.; Solli V.; Gabrielli L.; Leone M.; Pantani L.; Rocchi S.; Rizzello I.; Tac...chetti P.; Ghibellini S.; Favero E.; Ursi M.; Talarico M.; Barbato S.; Kanapari A.; Bigi F.; Puppi M.; Terragna C.; Borsi E.; Martello M.; Poletti A.; Scata A.; Nepoti G.; Ruffini B.; Lazzarotto T.; Cavo M. | 2023-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | 2023 Mancuso K ematologia fonc-13-1208741.pdf; Data Sheet 1.docx |
Multidisciplinary Management of Sternal Osteomyelitis Due to Klebsiella aerogenes after Open Heart Surgery in a Patient with Multiple Myeloma: A Case Report and Discussion of the Literature | Pignatti, Marco; Dolci, Giampiero; Zamagni, Elena; Pascale, Renato; Piccin, Ottavio; Ammar, Aless...andro; Zeneli, Flavia; Miralles, Maria Elisa Lozano; Mancuso, Katia; Cipriani, Riccardo; Viale, Pierluigi; Pacini, Davide; Martin-Suàrez, Sofia | 2023-01-01 | MICROORGANISMS | - | 1.01 Articolo in rivista | Multidisciplinary Management of Sternal Osteomyelitis Due to Klebsiella aerogenes after Open Heart Surgery in a Patient with Multiple Myeloma- A Case Report and Discussion of the Literature.pdf |
Multiple Myeloma Prognosis From PET Images: Deep Survival Losses and Contrastive Pretraining | Morvan L.; Nanni C.; Michaud A.-V.; Jamet B.; Bailly C.; Bodet-Milin C.; Chauvie S.; Touzeau C.; ...Moreau P.; Zamagni E.; Kraeber-Bodere F.; Carlier T.; Mateus D. | 2023-01-01 | IEEE TRANSACTIONS ON RADIATION AND PLASMA MEDICAL SCIENCES | - | 1.01 Articolo in rivista | - |
New Developments in Myeloma Treatment and Response Assessment | Kraeber-Bodere F.; Jamet B.; Bezzi D.; Zamagni E.; Moreau P.; Nanni C. | 2023-01-01 | THE JOURNAL OF NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | 1331.full.pdf |
Oxytocin modulates osteogenic commitment in human adipose-derived mesenchymal stem cells | Giovannamaria Petrocelli, Provvidenza Maria Abruzzo, Luca Pampanella, Riccardo Tassinari, Serena ...Marini, Martina Fazzina, Elena Zamagni, Carlo Ventura, Federica Facchin, Silvia Canaider | 2023-01-01 | - | - | 4.02 Riassunto (Abstract) | - |